Cost-effectiveness analysis of dyevert™ Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain

Literals

ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85161692546&origin=inward
vivo:identifier
- 2023-2099
dcterms:creator
- López-Mínguez J.R.
dcterms:contributor
- Lopez-Minguez J.R.; Martin de Francisco A.L.; Soler M.J.; Hernandez F.; Moreno R.; Pinar E.; Sampedro A.; Mareque M.; Oyaguez I.
ou:eid
- 2-s2.0-85161692546
fabio:hasPublicationYear
- 2023
bibo:eissn
- 1522-726X
bibo:doi
- 10.1002/ccd.30744
bibo:issn
- 1522-1946
bibo:page_range
- 233-240
dcterms:publisher
- Catheterization and Cardiovascular Interventions
ou:tipoPublicacion
- Article
dcterms:title
- Cost-effectiveness analysis of dyevert™ Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85161692546&origin=inward
ou:vecesCitado
- 0
bibo:volume
- 102